Risk of Heparin-induced Immediate-type Hypersensitivity during Arteriovenous Fistula Placement

Heparin is commonly used to prevent clotting; however, severe hypersensitivity reactions during vascular access (VA) placement are rarely but occasionally reported. A 49-year-old man experienced a heparin-induced hypersensitivity reaction during VA placement. Severe side effects may occur even while...

Descripción completa

Detalles Bibliográficos
Autores principales: Ihara, Katsuhito, Ohashi, Atsuki, Inoshita, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148165/
https://www.ncbi.nlm.nih.gov/pubmed/29526971
http://dx.doi.org/10.2169/internalmedicine.9705-17
_version_ 1783356713506701312
author Ihara, Katsuhito
Ohashi, Atsuki
Inoshita, Seiji
author_facet Ihara, Katsuhito
Ohashi, Atsuki
Inoshita, Seiji
author_sort Ihara, Katsuhito
collection PubMed
description Heparin is commonly used to prevent clotting; however, severe hypersensitivity reactions during vascular access (VA) placement are rarely but occasionally reported. A 49-year-old man experienced a heparin-induced hypersensitivity reaction during VA placement. Severe side effects may occur even while placing the VA; therefore, we reconsidered the routine use of heparin, as the side effects are unpredictable. Physicians should be aware of the risk of heparin-induced hypersensitivity and be ready to effectively manage it during VA placement.
format Online
Article
Text
id pubmed-6148165
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Japanese Society of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-61481652018-09-25 Risk of Heparin-induced Immediate-type Hypersensitivity during Arteriovenous Fistula Placement Ihara, Katsuhito Ohashi, Atsuki Inoshita, Seiji Intern Med Case Report Heparin is commonly used to prevent clotting; however, severe hypersensitivity reactions during vascular access (VA) placement are rarely but occasionally reported. A 49-year-old man experienced a heparin-induced hypersensitivity reaction during VA placement. Severe side effects may occur even while placing the VA; therefore, we reconsidered the routine use of heparin, as the side effects are unpredictable. Physicians should be aware of the risk of heparin-induced hypersensitivity and be ready to effectively manage it during VA placement. The Japanese Society of Internal Medicine 2018-03-09 2018-08-15 /pmc/articles/PMC6148165/ /pubmed/29526971 http://dx.doi.org/10.2169/internalmedicine.9705-17 Text en Copyright © 2018 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/ The Internal Medicine is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Ihara, Katsuhito
Ohashi, Atsuki
Inoshita, Seiji
Risk of Heparin-induced Immediate-type Hypersensitivity during Arteriovenous Fistula Placement
title Risk of Heparin-induced Immediate-type Hypersensitivity during Arteriovenous Fistula Placement
title_full Risk of Heparin-induced Immediate-type Hypersensitivity during Arteriovenous Fistula Placement
title_fullStr Risk of Heparin-induced Immediate-type Hypersensitivity during Arteriovenous Fistula Placement
title_full_unstemmed Risk of Heparin-induced Immediate-type Hypersensitivity during Arteriovenous Fistula Placement
title_short Risk of Heparin-induced Immediate-type Hypersensitivity during Arteriovenous Fistula Placement
title_sort risk of heparin-induced immediate-type hypersensitivity during arteriovenous fistula placement
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148165/
https://www.ncbi.nlm.nih.gov/pubmed/29526971
http://dx.doi.org/10.2169/internalmedicine.9705-17
work_keys_str_mv AT iharakatsuhito riskofheparininducedimmediatetypehypersensitivityduringarteriovenousfistulaplacement
AT ohashiatsuki riskofheparininducedimmediatetypehypersensitivityduringarteriovenousfistulaplacement
AT inoshitaseiji riskofheparininducedimmediatetypehypersensitivityduringarteriovenousfistulaplacement

Ejemplares similares